Dalissa Delgadillo

Dalissa Delgadillo is a kidney transplant recipient who has been facing significant challenges in accessing her essential medication, Myfortic 360 mg, which is crucial for preventing organ rejection. After 12 years post-transplant, she expressed her concerns about a two-month delay in receiving the medication, which she can no longer afford out-of-pocket due to the high costs exceeding RD$30,000 monthly. Dalissa’s story highlights the struggles many patients endure when navigating healthcare systems and the importance of reliable access to life-saving medications.